These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 29311397)
21. Prognostic significance of postoperative change of PALBI grade for patients with hepatocellular carcinoma after hepatectomy. Wang ZX; Peng W; Zhang XY; Wen TF; Li C Medicine (Baltimore); 2021 Mar; 100(11):e24476. PubMed ID: 33725934 [TBL] [Abstract][Full Text] [Related]
22. Hepatocyte nuclear factor 1β is a novel prognostic marker independent of the Milan criteria in transplantable hepatocellular carcinoma: a retrospective analysis based on tissue microarrays. Shim JH; Lee HC; Han S; Kang HJ; Yu E; Lee SG Liver Transpl; 2013 Mar; 19(3):336-45. PubMed ID: 23203386 [TBL] [Abstract][Full Text] [Related]
23. Patients with early recurrence of hepatocellular carcinoma have poor prognosis. Kobayashi T; Aikata H; Kobayashi T; Ohdan H; Arihiro K; Chayama K Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):279-288. PubMed ID: 28603096 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma. Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027 [TBL] [Abstract][Full Text] [Related]
25. Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy. Liu Y; Wang ZX; Cao Y; Zhang G; Chen WB; Jiang CP Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):266-74. PubMed ID: 27298102 [TBL] [Abstract][Full Text] [Related]
26. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227 [TBL] [Abstract][Full Text] [Related]
27. Edmondson-Steiner grade: A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio. Zhou L; Rui JA; Zhou WX; Wang SB; Chen SG; Qu Q Pathol Res Pract; 2017 Jul; 213(7):824-830. PubMed ID: 28554743 [TBL] [Abstract][Full Text] [Related]
28. α-Fetoprotein is a potential survival predictor in hepatocellular carcinoma patients with hepatitis B selected for liver transplantation. Zhang Q; Shang L; Zang Y; Chen X; Zhang L; Wang Y; Wang L; Liu Y; Mao S; Shen Z Eur J Gastroenterol Hepatol; 2014 May; 26(5):544-52. PubMed ID: 24614696 [TBL] [Abstract][Full Text] [Related]
29. Hangzhou criteria are more accurate than Milan criteria in predicting long-term survival after liver transplantation for HCC in Germany. Qu Z; Ling Q; Gwiasda J; Xu X; Schrem H; Beneke J; Kaltenborn A; Krauth C; Mix H; Klempnauer J; Emmanouilidis N Langenbecks Arch Surg; 2018 Aug; 403(5):643-654. PubMed ID: 30120543 [TBL] [Abstract][Full Text] [Related]
30. Anatomic resection and wide resection margin play an important role in hepatectomy for hepatocellular carcinoma with peritumoural micrometastasis. Shi C; Zhao Q; Liao B; Dong Z; Wang C; Yang J; Shen W ANZ J Surg; 2019 Nov; 89(11):E482-E486. PubMed ID: 31618805 [TBL] [Abstract][Full Text] [Related]
31. Prognoses, outcomes, and clinicopathological characteristics of very elderly patients with hepatocellular carcinoma who underwent hepatectomy. Shimada S; Kamiyama T; Orimo T; Nagatsu A; Asahi Y; Sakamoto Y; Kamachi H; Taketomi A World J Surg Oncol; 2020 Jun; 18(1):122. PubMed ID: 32522259 [TBL] [Abstract][Full Text] [Related]
32. Alpha fetoprotein changes predict hepatocellular carcinoma survival beyond the Milan criteria after hepatectomy. Shen JY; Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ J Surg Res; 2017 Mar; 209():102-111. PubMed ID: 28032546 [TBL] [Abstract][Full Text] [Related]
33. Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria. Lei Z; Li J; Wu D; Xia Y; Wang Q; Si A; Wang K; Wan X; Lau WY; Wu M; Shen F JAMA Surg; 2016 Apr; 151(4):356-63. PubMed ID: 26579636 [TBL] [Abstract][Full Text] [Related]
34. Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study. Liu J; Zhu Q; Li Y; Qiao GL; Xu C; Guo DL; Tang J; Duan R Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):330-338. PubMed ID: 29551612 [TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: clinicopathological and prognostic analysis of 390 cases. Chu KJ; Lu CD; Dong H; Fu XH; Zhang HW; Yao XP Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):192-9. PubMed ID: 24370644 [TBL] [Abstract][Full Text] [Related]
36. AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma. Yaprak O; Akyildiz M; Dayangac M; Demirbas BT; Guler N; Dogusoy GB; Yuzer Y; Tokat Y Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):256-61. PubMed ID: 22672818 [TBL] [Abstract][Full Text] [Related]
37. Optimal duration of the early and late recurrence of hepatocellular carcinoma after hepatectomy. Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E World J Gastroenterol; 2015 Jan; 21(4):1207-15. PubMed ID: 25632194 [TBL] [Abstract][Full Text] [Related]
38. Long-term outcomes after hepatectomy of huge hepatocellular carcinoma: A single-center experience in China. Fang Q; Xie QS; Chen JM; Shan SL; Xie K; Geng XP; Liu FB Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):532-537. PubMed ID: 31543313 [TBL] [Abstract][Full Text] [Related]